OGI logo

OrganiGram Holdings (OGI) News & Sentiment

Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
OGI
businesswire.comMarch 3, 2025

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T.

Organigram Is A Small-Cap Bargain
Organigram Is A Small-Cap Bargain
Organigram Is A Small-Cap Bargain
OGI
seekingalpha.comFebruary 23, 2025

Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio of 3.3X, mitigating many risks.

Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
OGI
seekingalpha.comFebruary 11, 2025

Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.

OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OGI
zacks.comFebruary 11, 2025

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago.

Organigram Reports First Quarter Fiscal 2025 Results
Organigram Reports First Quarter Fiscal 2025 Results
Organigram Reports First Quarter Fiscal 2025 Results
OGI
businesswire.comFebruary 11, 2025

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (“Q1 Fiscal 2025”). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill.

Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
OGI
businesswire.comFebruary 4, 2025

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2025 ended December 31, 2024, on Tuesday, February 11, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 11, 2025 Time: 8:00 am Easte.

Organigram Reports Fourth Quarter and Fiscal 2024 Results
Organigram Reports Fourth Quarter and Fiscal 2024 Results
Organigram Reports Fourth Quarter and Fiscal 2024 Results
OGI
businesswire.comDecember 18, 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (“Q4 Fiscal 2024” or “Fiscal 2024”). All financial information in this press release is expressed in Canadian dollars (“$”). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended.

Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
OGI
seekingalpha.comDecember 18, 2024

Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good morning. My name is Rob, and I will be your conference operator today.

Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
OGI
businesswire.comDecember 11, 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0.

OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OGI
marketwatch.comDecember 6, 2024

OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.